NHS, industry and the charitable sector collaborate to spread best practice in hepatitis C prevention, diagnosis, treatment and patient support
The first Quality in Care (QiC) Hepatitis C programme is now open for
entry to teams and individuals working within the field of hepatitis C.
Launched last week at the International Liver Congress in London, QiC
Hepatitis C recognises, rewards and shares good practice in hepatitis C
prevention, diagnosis & testing, treatment pathways and patient
support throughout the UK.
To support improved healthcare in this area, QiC Hepatitis C comprises
both an awards event and subsequent dissemination opportunities, and has
the endorsement, support and active participation of key stakeholders,
including the British Liver Trust, the Hepatitis C Trust, Bristol-Myers
Squibb and Gilead Sciences.